2,3-dinor-thromboxane b2 has been researched along with Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, S; Lorenz, RL; Ruetzel, A; Uedelhoven, WM; Weber, PC | 1 |
| Catella, F; Fitzgerald, DJ; FitzGerald, GA; Lawson, JA | 1 |
2 other study(ies) available for 2,3-dinor-thromboxane b2 and Vascular Diseases
| Article | Year |
|---|---|
A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator.
Topics: Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Humans; Radioimmunoassay; Risk Factors; Thromboxane B2; Vascular Diseases | 1989 |
Analysis of multiple thromboxane metabolites in plasma and urine.
Topics: Aspirin; Humans; Thromboxane B2; Thromboxanes; Vascular Diseases | 1987 |